Analysis of clinical distribution and drug-resistance of 118 strains of Acinetobacter
Shufeng Zhang
Abstract
Shufeng Zhang
Abstract
Objective:To study the distribution and drug resistance of Acinetobacter,in a hospital,so as to provide the reference for rational use of antimicrobial agents.Methats:Acinetobacter isolated from inpatients from January,2005 to January,2009 were identified with ATB Expression microbial identification and drug sensitivity system.Results:A total of 118 strains of Acinetobacter were isolated,most Acinetobacter spp were Acinetobacter baumannii and Acinetobacter calclaceticus,the drug-resistant rate to Ampicillin/sulbactam was 80% respectivdy,drug-resistant rate to Gentamicin,tobramycin,Trimethoprim/sulifa were boty 60%;the drug-resistant rate to Piperacillin,Ticarcillin,Ciprofloxacin,Ceftazidime,Cefepime were both 40%;the drug-resistant rate to Ticarcillin/ca,Piperacillin/tazobacta,Amikacin were both30%;The drug-resistant rate to Imipenem and Meropenem were all low was 5%.Conclusion:Acinetobacter is one of the common bacteria in nosocomial infection.The drug-resistant of Acinetobacter is very serious,it is important to monitor the antimicriobial resistance of Acinetobacter.clinical doctors should use antimicriobial agents rationally and slow down the producing of drug-resistant.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the distribution and drug resistance of Acinetobacter,in a hospital,so as to provide the reference for rational use of antimicrobial agents.Methats:Acinetobacter isolated from inpatients from January,2005 to January,2009 were identified with ATB Expression microbial identification and drug sensitivity system.Results:A total of 118 strains of Acinetobacter were isolated,most Acinetobacter spp were Acinetobacter baumannii and Acinetobacter calclaceticus,the drug-resistant rate to Ampicillin/sulbactam was 80% respectivdy,drug-resistant rate to Gentamicin,tobramycin,Trimethoprim/sulifa were boty 60%;the drug-resistant rate to Piperacillin,Ticarcillin,Ciprofloxacin,Ceftazidime,Cefepime were both 40%;the drug-resistant rate to Ticarcillin/ca,Piperacillin/tazobacta,Amikacin were both30%;The drug-resistant rate to Imipenem and Meropenem were all low was 5%.Conclusion:Acinetobacter is one of the common bacteria in nosocomial infection.The drug-resistant of Acinetobacter is very serious,it is important to monitor the antimicriobial resistance of Acinetobacter.clinical doctors should use antimicriobial agents rationally and slow down the producing of drug-resistant.
Key concepts: Acinetobacter, Ticarcillin, Cefepime, Piperacillin, Meropenem, Microbiology, Imipenem, Drug resistance